Immunovant, Inc. (IMVT) has a market capitalization of $5.4B and trades at $26.55. The 52-week range is 12.72-29.25.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -9.7, Earnings Per Share (EPS) of $-2.73.
The stock has a beta of 0.67, operates in the Healthcare sector.
